Safety and blood-drug study of XFB19 in healthy adults
This Phase 1 study tests whether XFB19 is safe and tolerable in healthy adults and how the drug moves through the body (what the blood levels look like). You would be in the study to help researchers understand early safety and dosing information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign informed consent and understand the study risks and purpose
- You are 18 to 55 years old and your weight and body size are within set limits
- You have not used tobacco or marijuana (including e-cigarettes) for at least 1 month before dosing
- You are generally healthy, with normal test results for heart rate, blood pressure, temperature, blood/urine tests, and an ECG with acceptable QT timing
- You can provide blood samples and you agree to follow the study schedule and restrictions
- If you can become pregnant or can get a partner pregnant, you must use effective birth control and follow study pregnancy/donation rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.
This early-stage study tests whether a new drug called FB102 is safe in people without serious health conditions. Researchers will monitor volunteers closely to understand how the body handles the drug.
This early-phase trial tests an experimental oral medication called FB-101 in healthy adult men to check its safety and how the body processes it. It's a first step to see if the drug is safe enough for future studies in patients.
This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This is a first-in-human study testing a new drug called XmAb412 in healthy volunteers. It helps researchers understand how the drug works in the body and if it's safe.
Hear when a new Focus of the Study: Safety of XFB19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.